Correction|Volume 13, Issue 20|pp 23871

Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression

Pol Andrés‐Benito^1,^2,³, Raúl Domínguez⁴, Maria J. Colomina⁵, Franc Llorens^2,³, Mònica Povedano⁴, Isidre Ferrer^1,^2,^3,^6,⁷

¹Department of Pathology and Experimental Therapeutics, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
²Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L’Hospitalet de Llobregat, Barcelona, Spain
³Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
⁴Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain
⁵Anesthesia and Critical Care Department, Bellvitge University Hospital ‐ University of Barcelona L’Hospitalet de Llobregat, Barcelona, Spain
⁶Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
⁷Institute of Neurosciences, University of Barcelona, Barcelona, Spain

Received: October 25, 2021Accepted: October 28, 2021Published: October 31, 2021

https://doi.org/10.18632/aging.203667

Copyright: © 2021 Andrés‐Benito et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: YKL40 values in text and figures represent ng/mL, not pg/mL This alteration does not affect the results or conclusions of this work.